Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by No Insulinlie Growth Factor 1

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT03932162Early Phase 1Recruiting

Gene Expression Changes In Young and Geriatric Skin

NCT02139410Completed

IGF-1, Sarcopenia and Mortality: a Cohort Study in Patient With Cognitive Impairment

Showing all 2 trials

Research Network

Common Treatments

  • No Insulinlie Growth Factor 11
  • Igf1 Serum Value1
  • Insulinlike Growth Factor 11

Active Sponsors

  • University of Roma La Sapienza1
  • Wright State University1

Top Investigators

Related Conditions

  • Aging1
  • Uvb Phototherapy Burn1
  • Cognitive Impairment1

Activity Timeline